Patients shouldn’t need to exercise patience when it comes to getting needed rheumatologic care. E-consults are an evolving telehealth modality with the potential to improve access to rheumatologic care in a cost-effective and efficient manner.
Enabling rheumatology practices to use complex administration codes for biologic drugs is critical for maintaining patient access to essential therapies.
Healthcare law is ever changing, particularly with regard to price transparency. Key healthcare leaders and stakeholders have long argued for more stringent price transparency regulations in an effort to increase patient awareness regarding the cost of a hospital item or service prior to receiving the service. Such information is anticipated to enable patients to take…
The reassurance comes after ACR leadership sent a letter detailing how its prior authorization forms increased paperwork burden for many biologic drugs and hurt patients’ timely access to treatment.
Participation in the American Medical Association Relative Value Update Committee surveys contributes to the accurate valuation of rheumatology services.
A new law in Texas establishes a continuous prior authorization exemption for physicians who earn a 90% approval rate on prior authorization requests for a given service over a period of six months.
The ACR highlights essential information for providers for 2022 MIPS reporting in the 2022 Medicare Physician Fee Schedule Final Rule, published Nov. 2.
The new rheumatology-specific Merit-Based Incentive Payment System Value Pathway will focus on measures that most rheumatologists already track. The model should streamline reporting and better target quality improvements.